The Veterinary Drug Approval Process and FDA Regulatory Oversight
This three-day interactive seminar will provide attendees with an understanding of FDA’s veterinary drug approval process.
The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) is responsible for the approval of veterinary drug products intended for family pets, food-producing animals, and other animal species. This seminar will cover the process for obtaining federal government approval for marketing new animal drug products that are under the jurisdiction of the FDA, and also briefly covers animal products that are regulated by other federal agencies. For example, animal vaccines, animal disease diagnostic devices and some animal biologics are regulated by the U.S. Department of Agriculture, and some flea and tick control products are regulated by the Environmental Protection Agency.
This three-day interactive seminar will provide attendees with an understanding of FDA’s veterinary drug approval process. The group size is small, generally between 8 and 20 people, with plenty of opportunities to ask questions and discuss issues or challenges that the attendees have experienced.
Organisation: Compliance Online
Info: October 20-22, 2021 (9:00 AM to 1:00 PM PDT) Virtual Training Through WebEx Various parts of the country are still battling the Coronavirus (COVID-19), we will conduct the class 100% online.